Biotech

All Articles

Exelixis goes down ADC after deciding it's no match for Tivdak

.Exelixis is actually surrendering on its own tissue variable (TF)- targeting antibody-drug conjugat...

Relay dislikes SHP2 inhibitor after Genentech leaves behind

.Three weeks after Roche's Genentech unit left an SHP2 inhibitor pact, Relay Rehab has verified that...

Stoke's Dravet disorder med released of partial medical grip

.Stoke Therapeutics' Dravet syndrome medicine has actually been freed from a predisposed grip, clear...

Fierce Biotech's Gabrielle Masson shows Strong 15 at NYSE

.Ferocious Biotech Associate Editor Gabrielle Masson offered the 2024 training class of Brutal 15 vi...

Daiichi pays for Merck $170M to create lung cancer T-cell engager contract

.Merck &amp Co. has quickly redeemed a number of the costs of its Weapon Therapeutics acquistion, dr...

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin administered a spring season clean of its pipe in April, the company has chosen that...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks work

.Large Pharmas remain stuck to the tip of molecular adhesive degraders. The most up to date provider...

Life science credit report agency introduces with $600M

.A brand-new global lifestyle scientific research debt organization, dubbed Symbiotic Funding, has a...

BMS trenches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing one more major bet coming from the Caforio time, terminating a packag...

Nuvation standstills wager prevention after taking into consideration phase 1 data

.After taking a look at period 1 information, Nuvation Bio has determined to stop work on its one-ti...